Table 4. Comparison of MIR, MV% and incidence AAR with India specific standard as given in IARC technical report no. 43.
| ICD-10 | Cancer site | MV% | MIR in % | AAR per 105 | |||
|---|---|---|---|---|---|---|---|
| Study | Standard | Study | Standard | Study | Standard | ||
| Males | |||||||
| C00–14 | Oral cavity and Pharynx | 93.4 | 87.3 | 53.0 | 32.0 | 18.0 | 19.9 |
| C15 | Oesophagus | 77.3 | 76 | 75.0 | 48.8 | 2.5 | 7.2 |
| C16 | Stomach | 90.9 | 72.1 | 85.0 | 47.8 | 2.5 | 5.6 |
| C18–21 | Large bowel | 95.5 | 81.1 | 79.6 | 31.9 | 2.5 | 5.3 |
| C22 | Liver | 76.9 | 76.0 | 93.0 | 53.7 | 0.7 | 2.9 |
| C25 | Pancreas | 68.8 | 59.9 | 35.0 | 51.3 | 0.9 | 1.7 |
| C32 | Larynx | 100 | 81.0 | 35.0 | 38.6 | 1 | 6 |
| C33–34 | Trachea, bronchus and Lung | 86 | 71.3 | 71.0 | 49.5 | 2.8 | 10.8 |
| C43 | Melanoma of skin | 100 | 99.5 | 62.0 | 14.6 | 0.2 | 0.3 |
| C50 | Breast | 100 | 82.8 | 0.0 | 31.9 | 0.2 | 0.6 |
| C61 | Prostate | 87.9 | 78.7 | 60.0 | 38.1 | 1.7 | 5.1 |
| C62 | Testis | 88.9 | 88.2 | 27.0 | 17.1 | 0.6 | 0.7 |
| C64–66 | Kidney, renal pelvis and Ureter | 100 | 91.1 | 81.0 | 26.3 | 0.5 | 1.6 |
| C67 | Bladder | 90 | 78.6 | 69.0 | 30.6 | 1.2 | 3.3 |
| C70–72 | Brain, CNS | 90.5 | 87.7 | 44.0 | 32.1 | 1.1 | 3.3 |
| C73 | Thyroid | 100 | 83.0 | 36.0 | 24.0 | 0.2 | 1 |
| C81–88, C90 | Lymphomas | 100 | 98.1 | 43.8 | 34.2 | 4.1 | 6 |
| C91–95 | Leukaemia | 100 | 93.3 | 41.0 | 48.7 | 2.4 | 4.1 |
| C00–96 (excluding C44) | All sites excluding (non-melanoma skin cancer) | 90.8 | 80.3 | 59.0 | 40.2 | 48.8 | 101.6 |
| Females | |||||||
| C00–14 | Oral cavity and Pharynx | 96.2 | 86.6 | 47.6 | 27.9 | 8.9 | 8.5 |
| C15 | Oesophagus | 83.3 | 77.4 | 60.1 | 45.8 | 2.5 | 4.3 |
| C16 | Stomach | 80 | 68.9 | 80.1 | 48.7 | 1 | 2.7 |
| C18–21 | Large bowel | 91.7 | 79.4 | 37.6 | 34.6 | 2.2 | 4.1 |
| C22 | Liver | 80 | 69.8 | 78.0 | 56.9 | 0.5 | 1.1 |
| C25 | Pancreas | 63.6 | 52.1 | 67.0 | 49.7 | 0.5 | 1 |
| C32 | Larynx | 100 | 76.0 | 83.0 | 43.1 | 0.2 | 0.7 |
| C33–34 | Trachea, bronchus and Lung | 96.4 | 71.4 | 78.0 | 52.0 | 1.3 | 2.5 |
| C43 | Melanoma of skin | 100 | 99.4 | 19.0 | 13 | 0.3 | 0.2 |
| C50 | Breast | 91.3 | 85.7 | 42.0 | 24.5 | 13.4 | 24.1 |
| C53 | Cervix uteri | 94.7 | 87.5 | 44.0 | 24.9 | 4.6 | 17.3 |
| C54–55 | Corpus uteri, uterus unspecified | 96.9 | 86.4 | 39.0 | 31.6 | 1.6 | 2.8 |
| C56 | Ovary | 88.2 | 79.0 | 58.0 | 32.8 | 3.9 | 6 |
| C64–66 | Kidney, renal pelvis and Ureter | 80.0 | 89.3 | 15.0 | 31.1 | 0.4 | 0.7 |
| C67 | Bladder | 100.0 | 76.7 | 55.0 | 37.0 | 0.1 | 0.8 |
| C70–72 | Brain, CNS | 90.0 | 86.3 | 57.0 | 33.2 | 0.7 | 2.1 |
| C73 | Thyroid | 94.1 | 84.8 | 14.0 | 14.6 | 0.9 | 2.4 |
| C81–88, C90 | Lymphomas | 100 | 97.8 | 19.9 | 35.9 | 3.0 | 3.7 |
| C91–95 | Leukaemia | 100 | 92.5 | 38.0 | 48.2 | 1.8 | 2.9 |
| C00–96 (excluding C44) | All sites excluding non-melanoma skin cancer | 91.45 | 82.0 | 50.3 | 32.8 | 53.8 | 100.3 |